drugset / Trial / NCT02349542

Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty

NCT02349542 ↗

Phase 4 Completed 20 enrolled OrthoCarolina Research Institute, Inc.
NaSingle-groupOpen-labelHealth-services research

Summary

The purpose of this study is to evaluate the serum levels (pharmacokinetics) of bupivacaine in a series of patients undergoing simultaneous bilateral total knee arthroplasty with the use of a standardized periarticular injection containing free bupivacaine and liposomal bupivacaine.

Timeline

Start
2015-01
Primary completion
2016-11-01
Completion
2016-11-21

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 75 mg Other
Subject Bupivacaine Other / unclassified 266 mg Other

Indications